7-OH

The DEA is moving to ban the opioid-like kratom compound 7-OH, classifying it alongside substances such as heroin and LSD. This regulatory action would place products containing 7-OH in a restricted category due to their chemical similarities to controlled substances.

Missouri Attorney General Catherine Hanaway secured settlements with companies Relax Relief Rejuvenate Trading LLC and CBD American Shaman, halting in-state sales of the concentrated kratom compound 7-OH. The agreements end a legal dispute over whether 7-OH should be classified as a dangerous opioid or a regulated product.

Kratom and its active component 7-OH, which have opioid-like effects, are widely available in the US. Health secretary RFK Jr. is pushing to ban 7-OH, sparking conflict between proponents of the substances and regulators.

Missouri Attorney General Catherine Hanaway announced that Kansas City-based CBD American Shaman has agreed to stop selling kratom and 7-OH products in Missouri, following a lawsuit alleging deceptive marketing and public health risks. The company must cease in-state sales and advertising within 30 days, with potential penalties for violations.

Virginia has enacted a new law regulating kratom sales, requiring age restrictions, secure storage, risk labeling, and a ban on 7-OH, a potent kratom compound. The law, sponsored by Del. Joshua Cole and signed by Gov. Abigail Spanberger, addresses concerns about kratom's addictive potential and health risks.

Kratom poisonings in the US have increased significantly, with experts attributing the surge to synthetic derivatives like 7-OH. The CDC report highlights a 1,200% rise in poisonings over a decade, prompting warnings against blanket kratom bans that could harm individuals using natural kratom for pain management and addiction recovery.